Riska, M., Haryati, H., Suhartono, E. and Wanahari, T.A. 2022. Prognostic Value of the Systemic Immune-Inflammation Index in EGFR Mutation-Positive Lung Adenocarcinoma Patients Treated with Tyrosine Kinase Inhibitors. Jurnal Respirasi. 8, 3 (Sep. 2022), 133–139. DOI:https://doi.org/10.20473/jr.v8-I.3.2022.133-139.